Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-01

FDA Approved: PIRFENIDONE — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for pirfenidone as a generic product manufactured by ScieGen Pharmaceuticals for idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)